Abstract
Craniopharyngioma is a rare benign tumour originating from Rathke's pouch. This paper reports a tumour case studied with a set of markers defining protein–carbohydrate recognition. Expression of endogenous lectins and their reactive glycoligands is under differentiation-dependent control in many cell types. These parameters can be related to the degree of cell differentiation in tumours. Therefore, the expression patterns of endogenous lectins, namely galectins-1, -3, and -7, in the craniopharyngioma case were determined. Galectins-1 and -3 were also used to reveal glycoconjugates in cells and extracellular matrices, an approach that has heretofore relied largely on plant lectins. The staining pattern of craniopharyngioma is compared with that of two other types of ectodermally derived tumours, namely basal and squamous cell carcinomas. Clusters of polygonal and flattened cells with morphological characteristics of differentiated cells in the craniopharyngioma and the majority of poorly differentiated cells in squamous cell carcinomas were reactive with galectin-3. No binding of this probe was observed in cells of basal cell carcinomas and the majority of craniopharyngioma cells. In view of the lack of accessible binding in the basal layer of normal squamous epithelia where proliferative cells (including stem cells) are located, galectin-3 binding could be used to distinguish basal from suprabasal cells of squamous epithelial cells.
Similar content being viewed by others
References
Adams JC, Watt FM(1991) Expression of β1, β3, β4 and β5 integrins by human epidermal keratinocytes and non-differentiating keratinocytes. J Cell Biol 115: 829–841.
Akahani S, Nangia-Makker P, Inohara H, Kim HRC, Raz A (1997) Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl–2 family. Cancer Res 57: 5272–5276.
André S, Kojima S, Yamazaki N, Fink C, Kaltner H, Kayser K, Gabius H-J (1999) Galectins-1 and-3 and their ligands in tumor biology. J Cancer Res Clin Oncol 125: 461–474.
André S, Pieters RJ, Vrasidas I, Kaltner H, Kuwabara I, Liu F-T, Liskamp RMJ, Gabius H-J (2001) Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugates. Chem Bio Chem 2: 822–830.
Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM(1999) The descriptive epidemiology of craniopharyngioma. J Neurosurg 90: 584–585.
Choufani G, Nagy N, Saussez S, Marchant H, Bisshop P, Burchert M, Danguy A, Louryan S, Salmon I, Gabius H-J, Kiss R, Hassid S (1999) The level of expression of galectin-1, galectin-3, and Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in the head and neck cancers. Cancer 86: 2353–2363.
Danguy A, Camby I, Kiss R (2002) Galectins and cancer. Biochim Biophys Acta, in press.
Delorge S, Saussez S, Pelc P, Devroede B, Marchant H, Burchert M, Zeng F-Y, Danguy A, Salmon I, Gabius H-J, Kiss R, Hassid S (2000) Correlation of galectin-3/galectin-3-binding sites with low differentiation status in head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg 122: 834–841.
El Sissy NA, Rashad NA (1999) CK-13 in craniopharyngioma versus related odontogenic neoplasm and human enamel. East Mediter Health J 5: 490–502.
Eldevik OP, Blaivas M, Gabrielsen TO, Hald JK, Chandler WF (1996) Craniopharyngioma: Radiologic and histologic findings and recurrence. Am J Neuroradiol 17: 1441–1442.
François C, Van Velthoven R, De Lathower O, Moreno C, Peltier A, Kaltner H, Salmon I, Gabius H-J, Danguy A, Decaestecker C, Kiss R (1999) Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas. Am J Clin Pathol 112: 194–203.
Froňková V, Holíková Z, Liu F-T, Homolka J, Rijken DC, André S, Bovin NV, Smetana K Jr., Gabius H-J (1999) Simultaneous detection of endogenous lectins and their binding capacity at the single-cell level. Folia Biol (Praha) 45: 157–162.
Gabius H-J (1987) Endogenous lectins in tumors and the immune system. Cancer Invest 5: 39–46.
Gabius H-J (1997a) Animal lectins. Eur J Biochem 243: 543–576.
Gabius H-J (1997b) Concept of tumor lectinology. Cancer Invest 15: 454–464.
Gabius H-J (2000) Biological information transfer beyond the genetic code: The sugar code. Naturwissenschaften 87: 108–121.
Gabius H-J (2001) Glycohistochemistry: The why and how of detection and localization of endogenous lectins. Anat Histol Embryol 30: 3–31.
Gabius H-J, Gabius S (1992) Chemical and biochemical strategies for the preparation of glycohistochemical probes and their application in lectinology. Adv Lectin Res 5: 123–157.
Galvan M, Tsuboi S, Fukuda M, Baum LG (2000) Expression of specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1. J Biol Chem 275: 16730–17737.
Gordower L, Decaestecker C, Kacem Y, Lemmers A, Gusman J, Burchert M, Danguy A, Gabius H-J, Salmon I, Kiss R, Gambi I (1999) Galectin-3 and galectin-3-binding-site expression in human adult astrocytic tumors and related angiogenesis. Neuropathol Appl Neurobiol 25: 319–330.
Hirabayashi J, ed. (1997) Recent topics on galectins. Trends Glycosci Glycotechnol 9: 1–180.
Holíková Z, Smetana K Jr., Burchert M, Dvořánková B, Bovin NV, Klubal R, Bartůňková J, Liu F-T, Gabius H-J (1999) Expression of galectin-3, galectin-3-binding epitopes and of Gal/GalNAc-binding sites in keratinocytes of the adult human epidermis. El J Pathol Histol 5: 992.03.
Kaltner H, Stierstorfer B (1998) Animal lectins as cell adhesion molecules. Acta Anat 161: 162–179.
Kayser K, Zink S, Schneider T, Dienemann H, André S, Kaltner H, Schüring M-P, Zick Y, Gabius H-J (2000) Benign metastasizing leiomyoma of the uterus: Documentation of clinical, immunohistochemical and lectin-histochemical data of ten cases. Virchows Arch 437: 284–292.
Konstantinov KN, Shames B, Izuno G, Liu F-T (1994) Expression of ɛBP, a β-galactoside-binding soluble lectin, in normal and neoplastic epidermis. Exp Dermatol 3: 9–16.
Kopitz J, Von Reitzenstein C, André S, Kaltner H, Uhl J, Ehemann V, Cantz M, Gabius H-J (2001) Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J BiolChem 276: 35917–35923.
Kristopaitis T, Thomas C, Petruzelli GJ, Lee JM (2000) Malignant craniopharyngioma. Arch Pathol Lab Med 124: 1356–1360.
Kubo O, Tajika Y, Uchimuno H, Muragaki Y, Shimoda M, Hiyama H, Morishita K, Takakura K (1993) Immunohistochemical study of craniopharyngiomas. Noshuyo Byori 10: 131–134.
Kuwabara I, Kuwabara Y, Yang R-Y, Schuler M, Green DR, Zuraw BL, Hsu DK, Liu F-T (2002) Galectin-7 (PIG1: p53-induced gene 1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release. J Biol Chem 277: 3487–3497.
Lesot H, Peterková R, Schmitt R, Meyer J-M, Viriot L, Vonesch J-L, Senger B, Peterka M, Ruch J-V (1999) Initial features of the inner dental epithelium histo-morphogenesis in the first lower molar in mouse. Int J Dev Biol 43: 245–254.
Liu F-T, Hsu DK, Zuberi RI, Hill PN, Shenav A, Kuwabara I, Chen SC (1996) Modulation and functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domains. Biochemistry 35: 6073–6079.
Magnaldo T, Fowlis D, Darmon M (1998) Galectin-7, a marker of all types of stratified epithelia. Differentiation 63: 159–168.
Moore KL (1982) The Developing Human. Clinically Oriented Embryology, 3rd edn, Philadelphia: Saunders.
Oka Kawano N, Kobayashi I, Saegusa H, Fujii K (1997) Ciliated craniopharyngioma indicates histogenic relationship to Rathke cleft epithelium. Clin Neuropathol 16: 103–106.
Paulus W, Stockel C, Krauss J, Sorensen N, Roggendorf W(1997) Odontogenic classification of craniopharyngiomas: A clinicopathological study of 54 cases. Histopathology 30: 172–176.
Peterková R (1985) The common developmental origin and phylogenic aspects of teeth, rugae palatinae, and fornix vestibuli oris in the mouse. J Craniofacial Genetics Develop Biol 5: 89–104.
Peterková R, Peterka M, Vonesch J-L, Turečková J, Viriot J, Rauch J-V, Lesot H(1998) Correlation between apoptosis distribution and BMP-2 and BMP-4 expression in vestigial tooth primordial in mice. Eur J Oral Sci 106: 667–670.
Plzák J, Smetana K Jr., Betka J, Kodet R, Kaltner H, Gabius H-J (2000) Endogenous lectins (galectins-1 and-3) as probes to detect differentiation-dependent alterations in human squamous cell carcinomas of the oropharynx and larynx. Int J Mol Med 5: 369–372.
Plzák J, Smetana K Jr., Hrdličková E, Kodet R, Holíková Z, Liu F-T, Dvořánková B, Kaltner H, Betka J, Gabius H-J (2001) Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation. Int J Oncol 19: 59–64.
Plzák J, Holíková Z, Smetana K Jr., Dvořánková B, Hercogová J, Kaltner H, Motlík J, Gabius H-J (2002) Differentiation-dependent glycosylation of cells in squamous cell epithelia detected by a mammalian lectin. Cells Tissues Organs, in press.
Rappl G, Abken H, Muche JM, Sterry W, Tilgen W, André S, Kaltner H, Ugurel S, Gabius H-J, Reinhold U (2002) CD4+ CD7- leukemic T cells from patient with Sézary syndrome are protected from galectin-1-triggered T cell death. Leukemia 16: 840–845.
Schwarz G, Remmelink M, Decaestecker C, Gielen I, Budel V, Burchert M, Darro F, Danguy A, Gabius H-J, Salmon I, Kiss R (1999) Galectin fingerprinting in tumor diagnosis. Differential expression of galectin-3 and galectin-3-binding sites, but not galectin-1 in benign vs malignant uterine smooth muscle tumors. Am J Clin Pathol 111: 623–631.
Solís D, Jiménez-Barbero J, Kaltner H, Romero A, Siebert H-C, Von Der Lieth C-W, Gabius H-J (2001) Towards defining the role of glycans as hardware in information storage and transfer: Basic principles of experimental approaches and recent progress. Cells Tissues Organs 168: 5–23.
Turečková J, Sahlberg C, Aberg T, Ruch J-V, Thesleff I, Peterková R (1995) Comparison of expression of the msx-1, msx-2, BMP-2 and BMP-4 genes in the mouse upper diastemal and molar tooth primordia. Int J Dev Biol 39: 459–468.
Uematsu Y, Tanaka Y, Matsumoto H, Funahashi K, Itakura T, Komai N (1994) Histological analysis of craniopharyngiomas – with reference to their histological origin and differentiation. No To Shinkei 46: 271–276.
Vespa GNR, Lewis LA, Kozak KR, Moran M, Nguyen JT, Baum LC, Miceli MC (1999) Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. J Immunol 162: 799–806.
Warner NE (1990) Pituitary gland. In: Kissane JM, ed. Anderson's Pathology, Vol. 2, 9th edn. St. Louis: Mosby, pp. 1517–1543.
Yang RY, Hsu DK, Liu F-T (1996) Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 93: 6737–6742.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Plzák, J., Haninec, P., Smetana, K. et al. Craniopharyngioma: A Case Report and Comparative Galectin Histochemical Analysis. Histochem J 34, 117–122 (2002). https://doi.org/10.1023/A:1020934329211
Issue Date:
DOI: https://doi.org/10.1023/A:1020934329211